SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-041075
Filing Date
2023-11-14
Accepted
2023-11-14 16:05:51
Documents
33
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1506184
2 ex31-1.htm EX-31.1 17451
3 ex31-2.htm EX-31.2 17389
4 ex32-1.htm EX-32.1 7364
  Complete submission text file 0001493152-23-041075.txt   3343619

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE vblt-20230930.xsd EX-101.SCH 19866
6 XBRL CALCULATION FILE vblt-20230930_cal.xml EX-101.CAL 30104
7 XBRL DEFINITION FILE vblt-20230930_def.xml EX-101.DEF 60530
8 XBRL LABEL FILE vblt-20230930_lab.xml EX-101.LAB 178125
9 XBRL PRESENTATION FILE vblt-20230930_pre.xml EX-101.PRE 123271
27 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 172333
Mailing Address 320 HATCH DRIVE FOSTER CITY CA 94404
Business Address 320 HATCH DRIVE FOSTER CITY CA 94404 415-851-2410
Notable Labs, Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36581 | Film No.: 231405926
SIC: 2834 Pharmaceutical Preparations